SLS logo

SLS
SELLAS Life Sciences Group Inc

53,199
Mkt Cap
$854.81M
Volume
4,191.00
52W High
$6.14
52W Low
$0.9516
PE Ratio
-19.36
SLS Fundamentals
Price
$4.76
Prev Close
$5.20
Open
$5.60
50D MA
$4.44
Beta
0.71
Avg. Volume
5.84M
EPS (Annual)
-$0.2463
P/B
10.28
Rev/Employee
$0.00
$340.23
Loading...
Loading...
News
all
press releases
Dagco Inc. Purchases Shares of 577,540 SELLAS Life Sciences Group, Inc. $SLS
Dagco Inc. purchased a new stake in shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 577,540 shares of the company's stock, va...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Penny Stocks To Research - March 22nd
Kosmos Energy, Co-Diagnostics, SELLAS Life Sciences Group, JetBlue Airways, BigBear.ai, Banco Bradesco, and Bitfarms are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of very small companies that trade at low pricestypically under $5...
MarketBeat·14h ago
News Placeholder
Penny Stocks To Watch Now - March 21st
Kosmos Energy, Co-Diagnostics, SELLAS Life Sciences Group, JetBlue Airways, and BigBear.ai are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are...
MarketBeat·2d ago
News Placeholder
SLS Stock In Focus As Alliance Global Sees 92% Upside Following AML Trial Updates
The company will present preclinical data on SLS009 in a poster session at the American Association for Cancer Research.
Stocktwits·3d ago
News Placeholder
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up on Earnings Beat
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up Following Better-Than-Expected Earnings...
MarketBeat·3d ago
News Placeholder
SLS Stock Pops After-Hours As Loss Shrinks, Cash Swells — All Eyes On High Stakes AML Trial In 'Pivotal' 2026
The company’s cash stood at $71.8 million at the end of the year, marking the company’s strongest balance sheet so far.
Stocktwits·3d ago
News Placeholder
SELLAS Life Sciences Group (NASDAQ:SLS) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
SELLAS Life Sciences Group (NASDAQ:SLS - Get Free Report) posted its earnings results on Thursday. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.01...
MarketBeat·3d ago
News Placeholder
SLS Stock Jumps Overnight: ‘Potent’ AML Drug Data Ahead Of Cancer Summit Fuels Fresh Momentum
Investors are also watching the late-stage GPS immunotherapy trial, which is nearing final analysis with 72 of 80 survival events recorded.
Stocktwits·5d ago
News Placeholder
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 5.3% - Here's Why
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.3% - What's Next...
MarketBeat·6d ago
News Placeholder
SELLAS Life Sciences Group (NASDAQ:SLS) Trading 9.3% Higher - What's Next?
SELLAS Life Sciences Group (NASDAQ:SLS) Trading Up 9.3% - Time to Buy...
MarketBeat·10d ago
<
1
2
...
>

Latest SLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.